Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects

American Journal of Human Genetics

Volumn 70, Issue 3, 2002, Pages 604-611

  DeBaun, Michael R ^a,b   Niemitz, Emily L ^c   McNeil, D Elizabeth ^b   Brandenburg, Sheri A ^c   Lee, Maxwell P ^c   Feinberg, Andrew P ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL WALL DEFECT; ARTICLE; BECKWITH WIEDEMANN SYNDROME; BIRTH DEFECT; CANCER RISK; CHROMOSOME 11P; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; EMBRYONAL CARCINOMA; GENE; GENE H19; GENE LIT1; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEMIHYPERTROPHY; HUMAN; HYPOGLYCEMIA; MACROGLOSSIA; MACROSOMIA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; REGISTER; UNIPARENTAL DISOMY; UNTRANSLATED REGION;

EID: 0036182963     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/338934     Document Type: Article

References (32)

1. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: Occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS
2. Imprinting centre deletions in two PWS families: Implications for diagnostic testing and genetic counseling
3. Disruption of an imprinted gene cluster by a targeted chromosomal translocation in mice
4. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
5. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site
6. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann Syndrome Registry
7. Beckwith-Wiedemann syndrome
8. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome
9. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction
10. Cancer epigenetics takes center stage
11. Somatic mosaicism for partial paternal isodisomy in Wiedemann-Beckwith fertilization event
12. Imprinting of IGF2 and H19: Lack of reciprocity in sporadic Beckwith-Wiedemann syndrome
13. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KvLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting
14. KIP2 mutation in Beckwith-Wiedemann syndrome
15. Human KvLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements
16. LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids
17. Evidence that insulin is imprinted in the human yolk sac
18. Epigenetic lesions at the H19 locus in Wilms' tumour patients
19. Specific association of altered DNA methylation of the H19 gene with cancer risk in Beckwith-Wiedemann syndrome
20. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour
21. KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors
22. Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11p15 imprinted domain
23. Wiedemann-Beckwith syndrome: Presentation of clinical and cytogenetic data on 22 new cases and review of the literature
24. Relaxation of imprinted genes in human cancer
25. KIP2 gene and its analysis in the G401 Wilms' tumor assay
26. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain
27. Enhancer competition between H19 and Igf2 does not mediate their imprinting
28. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome
29. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor
30. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome
31. KIP2 indicates a role in Beckwith-Wiedemann syndrome